Preventive Care in Nursing and Midwifery Journal
Zanjan University of Medical Science
Sat, May 25, 2024
[Archive]
Volume 13, Issue 3 (6-2023)
PCNM 2023, 13(3): 9-18 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Ahmadi Afshar A, Rahmati M, Maleki A, Kamali K. The Effectiveness of Budesonide in the Treatment of Asthma Attacks in Children: A Systematic Review and Meta-Analysis. PCNM 2023; 13 (3) :9-18
URL: http://nmcjournal.zums.ac.ir/article-1-859-en.html
URL: http://nmcjournal.zums.ac.ir/article-1-859-en.html
Medical Doctor, Department of Medicine, Department of Pediatrics, Faculty of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran , maryamrahmati7777@gmail.com
Abstract: (744 Views)
Background: Severe and moderate asthma attacks are among the major causes of children’s visits to emergency departments.
Objectives: The present systematic review is conducted to assess the effectiveness of inhaled budesonide on hospitalization and clinical presentations in children with asthma.
Methods: A search was conducted on six English databases from 2000 to 2022. Quality assessment was done using Cochrane Collaboration’s tool for Assessing the Risk of Bias, and heterogeneity was assessed using I2. The risk of bias was calculated using a funnel plot and Begg and Egger tests. The data were analyzed using RevMan 5, and random effects, the risk ratio and means difference were reported with a 95% confidence interval.
Results: Totally, 1380 studies were identified. After the screening, ten studies with a sample size of 1859 were included in the systematic review. The asthma scores were improved following budesonide administration in 10 studies. Compared to the placebo, the effects of budesonide on hospitalization rate were not statistically significant, but they were statistically significant with zero heterogeneity compared to other corticosteroids. Compared to the placebo or oral corticosteroids, there were no significant differences in heart rate, respiratory rate, and oxygen saturation after budesonide administration.
Conclusion: The effects of inhaled corticosteroids were similar to other oral corticosteroids and the placebo. Considering the high heterogeneity of the studies, future studies with larger sample sizes and longer follow-ups are recommended.
Objectives: The present systematic review is conducted to assess the effectiveness of inhaled budesonide on hospitalization and clinical presentations in children with asthma.
Methods: A search was conducted on six English databases from 2000 to 2022. Quality assessment was done using Cochrane Collaboration’s tool for Assessing the Risk of Bias, and heterogeneity was assessed using I2. The risk of bias was calculated using a funnel plot and Begg and Egger tests. The data were analyzed using RevMan 5, and random effects, the risk ratio and means difference were reported with a 95% confidence interval.
Results: Totally, 1380 studies were identified. After the screening, ten studies with a sample size of 1859 were included in the systematic review. The asthma scores were improved following budesonide administration in 10 studies. Compared to the placebo, the effects of budesonide on hospitalization rate were not statistically significant, but they were statistically significant with zero heterogeneity compared to other corticosteroids. Compared to the placebo or oral corticosteroids, there were no significant differences in heart rate, respiratory rate, and oxygen saturation after budesonide administration.
Conclusion: The effects of inhaled corticosteroids were similar to other oral corticosteroids and the placebo. Considering the high heterogeneity of the studies, future studies with larger sample sizes and longer follow-ups are recommended.
Type of Study: Review Articels |
Subject:
other
Received: 2023/01/9 | Accepted: 2023/06/20 | Published: 2023/06/20
Received: 2023/01/9 | Accepted: 2023/06/20 | Published: 2023/06/20
References
1. Eder W, Ege MJ, von Mutius E. The asthma epidemic. New England Journal of Medicine. 2006; 355(21): 2226-35. [crossref]
2. Subbarao P, Mandhane PJ, Sears MR. Asthma: epidemiology, etiology and risk factors. Cmaj. 2009; 181(9): E181-E90. [crossref]
3. Asthma N. PP Third Expert Panel on the Diagnosis and Management of. Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma. National Heart. Lung, and Blood Institute (US). 2007.
4. Alangari AA, Malhis N, Mubasher M, Al-Ghamedi N, Al-Tannir M, Riaz M, et al. Budesonide nebulization added to systemic prednisolone in the treatment of acute asthma in children: a double-blind, randomized, controlled trial. Chest. 2014; 145(4): 772-8. [crossref]
5. Coutinho AE, Chapman KE. The anti-inflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insights. Molecular and cellular endocrinology. 2011; 335(1): 2-13. [crossref]
6. Rowe B, Vethanayagam D. The role of inhaled corticosteroids in the management of acute asthma. Eur Respiratory Soc; 2007. p. 1035-7. [crossref]
7. Pedersen S, Steffensen G, Ekman I, Tönnesson M, Borgå O. Pharmacokinetics of budesonide in children with asthma. European journal of clinical pharmacology. 1987; 31(5): 579-82. [crossref]
8. Chen AH, Zeng GQ, Chen RC, Zhan JY, Sun LH, Huang SK, et al. Effects of nebulized high-dose budesonide on moderate-to-severe acute exacerbation of asthma in children: a randomized, double-blind, placebo-controlled study. Respirology (Carlton, Vic). 2013;18 Suppl 3: 47-52. [crossref]
9. Razi CH, Cörüt N, Andıran N. Budesonide reduces hospital admission rates in preschool children with acute wheezing. Pediatric Pulmonology. 2017; 52(6): 720-8. [crossref]
10. Zhang L, Mendoza RA. Doses of systemic corticosteroids in hospitalised children with acute asthma: a systematic review. Journal of paediatrics and child health. 2006; 42(4): 179-83. [crossref]
11. Su X-M, Yu N, Kong L-F, Kang J. Effectiveness of inhaled corticosteroids in the treatment of acute asthma in children in the emergency department: a meta-analysis. Annals of medicine. 2014; 46(1): 24-30. [crossref]
12. Higgins JP, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD, et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. Bmj. 2011; 343. [crossref]
13. Arulparithi CS, Babu TA, Ravichandran C, Santhanam I, Sathyamurthi B, Parivathini S, et al. Efficacy of nebulised budesonide versus oral prednisolone in acute severe asthma. Indian journal of pediatrics. 2015; 82(4): 328-32. [crossref]
14. Nuhoğlu Y, Bahçeciler NN, Barlan IB, Müjdat Başaran M. The effectiveness of high-dose inhaled budesonide therapy in the treatment of acute asthma exacerbations in children. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology. 2001; 86(3): 318-22. [crossref]
15. Razi CH, Turktas I, Bakirtas A. Comparison of single 2,000-μg dose treatment vs sequential repeated-dose 500-μg treatments with nebulized budesonide in acute asthma exacerbations. Ann Allergy Asthma Immunol. 2008; 100(4): 370-6. [crossref]
16. Saito M, Kikuchi Y, Kawarai Lefor A, Hoshina M. High-dose nebulized budesonide is effective for mild asthma exacerbations in children under 3 years of age. European annals of allergy and clinical immunology. 2017; 49(1): 22-7.
17. Sekerel BE, Sackesen C, Tuncer A, Adalioglu G. The effect of nebulized budesonide treatment in children with mild to moderate exacerbations of asthma. Acta paediatrica (Oslo, Norway : 1992). 2005; 94(10): 1372-7.
https://doi.org/10.1080/08035250510039847 [crossref]
18. Upham BD, Mollen CJ, Scarfone RJ, Seiden J, Chew A, Zorc JJ. Nebulized budesonide added to standard pediatric emergency department treatment of acute asthma: a randomized, double-blind trial. Academic emergency medicine : official journal of the Society for Academic Emergency Medicine. 2011;18(7):665-73. [crossref]
19. Zeiger RS, Mauger D, Bacharier LB, Guilbert TW, Martinez FD, Lemanske RF, Jr., et al. Daily or intermittent budesonide in preschool children with recurrent wheezing. The New England journal of medicine. 2011;365(21):1990-2001. [crossref]
20. Castro‐Rodriguez JA, Pincheira MA, Escobar‐Serna DP, Sossa‐Briceño MP, Rodriguez‐Martinez CE. Adding nebulized corticosteroids to systemic corticosteroids for acute asthma in children: A systematic review with meta‐analysis. Pediatric Pulmonology. 2020;55(10):2508-17. [crossref]
21. Li C-Y, Liu Z. Effect of budesonide on hospitalization rates among children with acute asthma attending paediatric emergency department: a systematic review and meta-analysis. World Journal of Pediatrics. 2021;17(2):152-63. [crossref]
22. Murphy KR, Hong JG, Wandalsen G, Larenas-Linnemann D, El Beleidy A, Zaytseva OV, et al. Nebulized inhaled corticosteroids in asthma treatment in children 5 years or younger: a systematic review and global expert analysis. The Journal of Allergy and Clinical Immunology: In Practice. 2020; 8(6): 1815-27. [crossref]
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
